{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:10:41Z","timestamp":1720419041359},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.sleep.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T11:11:23Z","timestamp":1181646683000},"page":"S19-S24","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S2","title":["Challenging issues: Sleep\u2013wake, augmentation and quality of life"],"prefix":"10.1016","volume":"8","author":[{"given":"Markku","family":"Partinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2007.04.007_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib2","first-page":"146","article-title":"Failure of physician documentation of sleep complaints in hospitalized patients","volume":"169","author":"Meissner","year":"1998","journal-title":"West J Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.870100517","article-title":"Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group","volume":"10","author":"Walters","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib5","unstructured":"AASM. The International classification of sleep disorders. 2nd ed. Rochester, Minnesota: American Academy of Sleep Medicine (AASM); 2005."},{"key":"10.1016\/j.sleep.2007.04.007_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.46.1.92","article-title":"A questionnaire study of 138 patients with restless legs syndrome: the \u2019Night-Walkers\u2019 survey","volume":"46","author":"Walters","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.04.007_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archinte.165.1.35","article-title":"Prevalence and correlates of nonrestorative sleep complaints","volume":"165","author":"Ohayon","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(99)01376-8","article-title":"Impact of sleep debt on metabolic and endocrine function","volume":"354","author":"Spiegel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2007.04.007_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/sleep\/24.4.392","article-title":"Insufficient sleep \u2013 a population-based study in adults","volume":"24","author":"Hublin","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jacc.2003.07.050","article-title":"Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk","volume":"43","author":"Meier-Ewert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sleep.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1210\/jc.2004-1003","article-title":"Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin","volume":"89","author":"Spiegel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.sleep.2007.04.007_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.165.1.25","article-title":"Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index","volume":"165","author":"Vorona","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2869.1993.tb00062.x","article-title":"The severity of obstructive sleep apnoea is associated with insulin resistance","volume":"2","author":"Tiihonen","year":"1993","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2007.04.007_bib14","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1093\/sleep\/19.suppl_10.S218","article-title":"Metabolic aspects of sleep apnea","volume":"19","author":"Grunstein","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ehj.2004.02.021","article-title":"Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome","volume":"25","author":"Coughlin","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sleep.2007.04.007_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-005-0068-2","article-title":"Interactions between obstructive sleep apnea and the metabolic syndrome","volume":"5","author":"Svatikova","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.sleep.2007.04.007_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199801153380307","article-title":"Protective and damaging effects of stress mediators","volume":"338","author":"McEwen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1399-3003.2000.15b17.x","article-title":"Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea","volume":"15","author":"Grimpen","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2007.04.007_bib19","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1001\/jama.283.17.2235","article-title":"Chronic systemic inflammation in overweight and obese adults","volume":"283","author":"Vgontzas","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2007.04.007_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4065\/79.8.1036","article-title":"Obstructive sleep apnea and cardiovascular disease","volume":"79","author":"Parish","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2007.04.007_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","article-title":"Evaluating the quality of life of patients with restless legs syndrome","volume":"26","author":"Abetz","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2007.04.007_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality-of-life outcomes","volume":"334","author":"Testa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/sleep\/18.8.681","article-title":"L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial","volume":"18","author":"Trenkwalder","year":"1995","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/B:QURE.0000021322.22011.d0","article-title":"Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation","volume":"13","author":"Atkinson","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.sleep.2007.04.007_bib25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","article-title":"Evaluating the quality of life of patients with restless legs syndrome","volume":"26","author":"Abetz","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2007.04.007_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1524-4733.2005.03010.x","article-title":"Validation of the Restless Legs Syndrome Quality of Life questionnaire","volume":"8","author":"Abetz","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.sleep.2007.04.007_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The sickness impact profile: development and final revision of a health status measure","volume":"19","author":"Bergner","year":"1981","journal-title":"Med Care"},{"key":"10.1016\/j.sleep.2007.04.007_bib29","first-page":"221","article-title":"The Nottingham Health Profile: subjective status and medical consultations","volume":"15A","author":"Hunt","year":"1981","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib30","first-page":"226","article-title":"Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey","volume":"75","author":"Sevim","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2007.04.007_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00415-005-0604-7","article-title":"\u201cAnxietas tibiarum\u201d. Depression and anxiety disorders in patients with restless legs syndrome","volume":"252","author":"Winkelmann","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2007.04.007_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.sleep.2005.03.005","article-title":"Antidepressant medication use and restless legs syndrome in patients presenting with insomnia","volume":"6","author":"Brown","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib33","first-page":"891","article-title":"Restless legs syndrome, periodic limb movements in sleep, and depression","volume":"28","author":"Picchietti","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.20443","article-title":"Diagnosis and management of pergolide-induced fibrosis","volume":"20","author":"Hirani","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00702-005-0289-1","article-title":"Retrospective evaluation of cardio-pulmonary fibrotic side effects in symptomatic patients from a group of 234 Parkinson\u2019s disease patients treated with cabergoline","volume":"112","author":"Dhawan","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.sleep.2007.04.007_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: a double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.04.007_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-1331.2000.0070s1027.x","article-title":"Pramipexole in the treatment of restless legs syndrome: a follow-up study","volume":"7","author":"Montplaisir","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2007.04.007_bib39","article-title":"Pramipexole in restless legs syndrome. A randomized double blind study","author":"Partinen","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib40","unstructured":"Oertel W, Stiasny-Kolster K. Effective treatment of restless legs syndrome (RLS) with pramipexole: results of a 6-week, multi-centre, double blind, and placebo controlled study. Athens, Greece, 2005. Abstract # P2."},{"key":"10.1016\/j.sleep.2007.04.007_bib41","article-title":"Pramipexole is efficacious and safe in treating RLS patients: results of a 12 weeks placebo controlled, fixed dose study WASM 2005, Berlin, Germany","volume":"6","author":"Winkelman","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib42","unstructured":"Trenkwalder C, Stiasny-Kolster K, and GR-PSG. Sustained efficacy of Pramipexole in Restless Legs Syndrome. Sleep Med 2005;6:S73."},{"key":"10.1016\/j.sleep.2007.04.007_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/mds.20983","article-title":"Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome","author":"Trenkwalder","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib44","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1468-1331.2006.01459.x","article-title":"Long-term treatment with pramipexole in restless legs syndrome","volume":"13","author":"Montplaisir","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2007.04.007_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sleep.2006.03.011","article-title":"Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study \u2013 the PRELUDE study","volume":"7","author":"Partinen","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/01.WNL.0000113752.14744.15","article-title":"Pramipexole for the treatment of uremic restless legs in patients undergoing hemodyalisis","volume":"62","author":"Miranda","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.04.007_bib47","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/mds.21050","article-title":"Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial","volume":"21","author":"Montplaisir","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4065\/81.1.17","article-title":"Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bogan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2007.04.007_bib49","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1185\/030079906X132442","article-title":"Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points \u2013 data from the ropinirole clinical trial programme","volume":"22","author":"Giorgi","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sleep.2007.04.007_bib50","first-page":"A344","article-title":"Ropinirole versus placebo in the treatment of restless legs syndrome (RLS): a 12-week multicenter double-blind placebo-controlled study conducted in 6 countries","volume":"26","author":"Walters","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib51","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from a 12-week, randomised, placebo-controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2007.04.007_bib52","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.wnf.0000135480.78529.06","article-title":"Ropinirole as a treamtent of restless legs syndrome in patients on chronic hemodyalisis","volume":"27","author":"Pellecchia","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2007.04.007_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sleep.2004.12.002","article-title":"Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome","volume":"6","author":"Bliwise","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib55","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/01.WNL.0000120672.94060.F1","article-title":"Ropinirole for restless legs syndrome: a placebo-controlled crossover trial","volume":"62","author":"Adler","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.04.007_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sleep.2005.08.009","article-title":"Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome","volume":"7","author":"M\u00f6ller","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib57","first-page":"453","article-title":"Intravenous iron in treatment of restless legs (TARKISTA)","volume":"145","author":"Nordlander","year":"1953","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.sleep.2007.04.007_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00003495-200464020-00003","article-title":"Restless legs syndrome: an update on treatment options","volume":"64","author":"Schapira","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2007.04.007_bib59","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/WNL.64.12_suppl_3.S28","article-title":"New paradigms in the treatment of restless legs syndrome","volume":"64","author":"Thorpy","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.04.007_bib60","first-page":"805","article-title":"The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data","volume":"29","author":"Estivill","year":"1999","journal-title":"Rev Neurol"},{"key":"10.1016\/j.sleep.2007.04.007_bib61","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2007.04.007_bib62","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome . TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.04.007_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2003.09.005","article-title":"Augmentation: understanding a key feature of RLS","volume":"5","author":"Garcia-Borreguero","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib66","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archneur.61.9.1393","article-title":"Long-term treatment of restless legs syndrome with dopamine agonists","volume":"61","author":"Ondo","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2007.04.007_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sleep.2004.10.010","article-title":"An item response analysis of the international restless legs syndrome study group rating scale for restless legs syndrome","volume":"6","author":"Wunderlich","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome: an extended study","volume":"26","author":"Silber","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.04.007_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"Winkelman","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.04.007_bib71","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(80)91735-3","article-title":"Effect of naloxone in a previously undescribed hypothalamic syndrome. A disorder of the endogenous opioid peptide system?","volume":"1","author":"Dunger","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2007.04.007_bib72","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Movement Disorders: official journal of the Movement Disorder Society"},{"key":"10.1016\/j.sleep.2007.04.007_bib73","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4065\/79.7.916","article-title":"An algorithm for the management of restless legs syndrome","volume":"79","author":"Silber","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2007.04.007_bib74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.20359","article-title":"Methadone for refractory restless legs syndrome","volume":"20","author":"Ondo","year":"2005","journal-title":"Mov Disord"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T01:50:00Z","timestamp":1556502600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945707001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":74,"alternative-id":["S1389945707001335"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2007.04.007","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}